GE HealthCare Technologies (NASDAQ:GEHC) Cut to Hold at Wall Street Zen

Wall Street Zen downgraded shares of GE HealthCare Technologies (NASDAQ:GEHC) from a buy rating to a hold rating in a research report report published on Saturday.

Several other analysts also recently weighed in on GEHC. Citigroup reduced their target price on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a report on Wednesday, March 11th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and boosted their price objective for the company from $73.00 to $77.00 in a research note on Thursday, January 15th. Bank of America increased their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Finally, The Goldman Sachs Group restated a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $71.65 on Friday. The firm has a market capitalization of $32.69 billion, a P/E ratio of 15.71, a P/E/G ratio of 1.53 and a beta of 1.03. GE HealthCare Technologies has a 52 week low of $57.65 and a 52 week high of $89.77. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The firm’s 50 day moving average is $78.91 and its two-hundred day moving average is $78.45.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the previous year, the firm earned $1.45 EPS. The company’s revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts forecast that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 3.07%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of GEHC. Vanguard Group Inc. lifted its holdings in shares of GE HealthCare Technologies by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after purchasing an additional 267,058 shares during the period. Auto Owners Insurance Co increased its stake in GE HealthCare Technologies by 9,525.4% in the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after buying an additional 33,629,559 shares during the period. Dodge & Cox increased its stake in GE HealthCare Technologies by 13.4% in the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after buying an additional 3,693,918 shares during the period. Capital Research Global Investors raised its position in GE HealthCare Technologies by 1.6% during the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock worth $2,080,248,000 after buying an additional 389,796 shares during the last quarter. Finally, State Street Corp lifted its stake in shares of GE HealthCare Technologies by 2.0% in the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after acquiring an additional 401,932 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.